- ●Trichotillomania is recurrent pulling out of one's own hair (scalp, eyebrows, eyelashes, or elsewhere) resulting in hair loss, with repeated unsuccessful attempts to stop and significant distress or impairment.
- ●It is a body-focused repetitive behavior in the obsessive-compulsive-related disorders family — not a habit you can simply will away, and not self-harm in the usual sense.
- ●Pulling often happens automatically or to relieve tension/discomfort, and is frequently followed by shame; it commonly co-occurs with depression and anxiety.
- ●First-line treatment is a specific behavioral therapy — habit reversal training (a form of CBT) — which is more effective than medication for the pulling itself.
- ●N-acetylcysteine (NAC), a glutamate-modulating supplement, has randomized evidence in trichotillomania — notable because it points at the same glutamate system ketamine acts on.
- ●Ketamine is not an established treatment for trichotillomania; its relevance is the co-occurring depression or anxiety.
Clinical definition
How it differs from related conditions
vs. OCD
Same broad family and some shared circuitry, but trichotillomania is a body-focused repetitive behavior driven by urges and tension relief rather than by obsessions neutralized with compulsions.
BDD centers on perceived appearance flaws; trichotillomania centers on the hair-pulling behavior itself, though both are OCD-spectrum and can co-occur.
vs. Excoriation (skin-picking) disorder
The sibling body-focused repetitive behavior, with the same treatment approach (habit reversal); the two often co-occur.
vs. Depression / anxiety
Common comorbidities that both worsen pulling and follow from the shame of it; treated alongside.
First-line treatments
Habit reversal training (HRT)
The first-line behavioral therapy — awareness training, competing-response training, and stimulus control; more effective than medication for the pulling itself.
Comprehensive behavioral (ComB) and ACT-enhanced models
Extend HRT to address the sensory, cognitive, and emotional drivers of pulling.
N-acetylcysteine (NAC)
A glutamate-modulating supplement with randomized evidence for reducing hair-pulling; generally well-tolerated, though results vary.
Treating comorbid depression/anxiety
SSRIs help co-occurring mood and anxiety (their effect on the pulling itself is modest), reducing a common trigger.
When standard treatments fail
Where ketamine fits
Where this fits with Tovani
Frequently asked
Is trichotillomania just a bad habit?
No. It's a recognized body-focused repetitive behavior in the OCD-related family, driven by urges and tension relief, not a habit you can simply will away. Repeated attempts to stop and real distress are part of the diagnosis. It's treatable with specific behavioral therapy.
What actually stops hair-pulling?
Habit reversal training — a specific behavioral therapy (awareness training, a competing response, stimulus control) — is first-line and more effective than medication for the pulling itself. N-acetylcysteine has randomized evidence as an adjunct, and treating co-occurring depression or anxiety helps.
Is it related to OCD?
Yes — it's in DSM-5's obsessive-compulsive and related disorders, alongside skin-picking. But unlike classic OCD, the pulling is a body-focused repetitive behavior driven by urges and tension relief rather than obsessions and compulsions.
Can ketamine help?
It's not an established treatment for hair-pulling. There's an interesting mechanistic thread — NAC (glutamate-modulating) has evidence in trichotillomania, and ketamine also acts on glutamate — but that's research-level, not proof ketamine treats it. Its real role is a co-occurring treatment-resistant depression, alongside behavioral therapy.
References
- Grant JE et al. 2009, Archives of General Psychiatry — Randomized controlled trial of N-acetylcysteine, a glutamate modulator, reducing hair-pulling in trichotillomania. (PMID 19581567)
- Stein DJ et al. 2019, Nature Reviews Disease Primers — Review of obsessive-compulsive and related disorders, the family that includes trichotillomania, and their treatment. (PMID 31371720)
- Sanacora G et al. 2017, JAMA Psychiatry — APA consensus on ketamine, relevant to the depression that co-occurs with trichotillomania. (PMID 28249076)
Last reviewed by Dr. Ben Soffer, DO on May 31, 2026. This page is educational and not a substitute for clinical evaluation. A physician determines whether ketamine therapy is appropriate for your specific situation.